You are not logged in.

Post-cycle therapy for performance and image enhancing drug users: a qualitative investigation

Griffiths, Scott, Henshaw, Richard, McKay, Fiona H. and Dunn, Matthew 2016, Post-cycle therapy for performance and image enhancing drug users: a qualitative investigation, Performance enhancement and health, In Press, pp. 1-5, doi: 10.1016/j.peh.2016.11.002.

Attached Files
Name Description MIMEType Size Downloads

Title Post-cycle therapy for performance and image enhancing drug users: a qualitative investigation
Author(s) Griffiths, Scott
Henshaw, Richard
McKay, Fiona H.
Dunn, Matthew
Journal name Performance enhancement and health
Season In Press
Start page 1
End page 5
Total pages 5
Publisher Elsevier
Place of publication Amsterdam, The Netherlands
Publication date 2016-11
ISSN 2211-2669
Keyword(s) Anabolic androgenic steroids
post cycle therapy
steriods
mental health
cycle
Summary Anabolic-androgenic steroids (AAS) are synthetic forms of the hormone testosterone and their non-medical use is related to increased muscle size, muscle mass, and strength. A primary concern regarding exogenous AAS use is its potential to suppress endogenous (natural) testosterone production. In response, some users seek out substances to use post-cycle to mitigate problems associated with the resumption of endogenous testosterone production. This study sought to understand issues related to post-cycle therapy (PCT) among a sample of performance and image enhancing drugs (PIED) users in Australia. Semi-structured interviews were conducted with 26 participants (n = 24 male) who reported the use of a range of performance and image enhancing drugs (PIEDs), including AAS, human chorionic gonadotropin, growth hormone, clenbuterol, tamoxifen, insulin, and peptides. Interviews were conducted in person or by telephone, recorded, and transcribed. Data were analysed following a process of thematic analysis. Three themes emerged: (1) access to PCT; (2) maintenance of gains, maintenance of health; and (3) PCT and links to mental health. Steroids were seen as easier to access than PCT; as such, participants tended to continue to use steroids rather than taper down their use, leading to health concerns. Participants wanted access to PCT for several reasons, including minimising any loss of muscle or strength gained through their PIED cycle; because they were concerned that they were no longer naturally producing hormones; or because they were concerned about their mental health, particularly when coming 'off cycle', and the need for PCT to help adjust. This study contributes to the existing literature suggesting that PCT may act as a harm reduction measure, allowing PIED users to safely reduce or cease steroid use or to address any negative effects from use, particularly those related to mental health.
Language eng
DOI 10.1016/j.peh.2016.11.002
Field of Research 119999 Medical and Health Sciences not elsewhere classified
110306 Endocrinology
Socio Economic Objective 920414 Substance Abuse
HERDC Research category C1 Refereed article in a scholarly journal
ERA Research output type C Journal article
Copyright notice ©2016, Elsevier
Persistent URL http://hdl.handle.net/10536/DRO/DU:30090547

Document type: Journal Article
Collection: School of Health and Social Development
Connect to link resolver
 
Unless expressly stated otherwise, the copyright for items in DRO is owned by the author, with all rights reserved.

Versions
Version Filter Type
Citation counts: TR Web of Science Citation Count  Cited 0 times in TR Web of Science
Scopus Citation Count Cited 0 times in Scopus
Google Scholar Search Google Scholar
Access Statistics: 33 Abstract Views, 1 File Downloads  -  Detailed Statistics
Created: Thu, 12 Jan 2017, 10:15:55 EST

Every reasonable effort has been made to ensure that permission has been obtained for items included in DRO. If you believe that your rights have been infringed by this repository, please contact drosupport@deakin.edu.au.